Search

Prevent

About

Early screening to prevent pre-eclampsia complications

Prevent addresses the critical issue of pre-eclampsia, a leading cause of maternal and neonatal mortality, by introducing an innovative early screening test. Unlike traditional methods, the test identifies high-risk women between 11 and 16 weeks of pregnancy, allowing for early intervention. By detecting risk early, expectant mothers can receive preventive care, such as low-dose aspirin, well before symptoms develop. This proactive approach aims to improve outcomes and reduce the overall impact of pre-eclampsia

Challenges

# Female health

Trends

# Health

University

Student

  • Ella Fouhy

    Ella Fouhy

    I am a final-year PhD candidate in Biochemistry at University College Dublin, where my research centers on investigating the early circulating environment in maternal blood that precedes the diagnosis of pre-eclampsia. My work focuses on the potential of nanoparticles known as "Extracellular Vesicles," which I am exploring as novel biomarkers for disease detection and prediction. I am passionate about advancing maternal health through innovative research, and I aim to contribute to the development of more effective diagnostic tools for pregnancy-related complications. more

Discover
the
Project


Similiar Projects

AiSee

AiSee

Wearable technology

National University of Singapore

AI-powered wearable device for real-time visual assistance

AmCURE Antibiotic

AmCURE Antibiotic

Infection risk reduction

Targeted antimicrobial treatment for resistant infections

ANGIE

ANGIE

Patient comfort

ETH Zurich

Magnetically guided microcapsules for brain tumour treatment

Belly Buddy

Belly Buddy

Health and Well-being

Harvard University

Early detection and non-invasive correction of breech pregnancies